LONDON, July 2, 2013 /PRNewswire/ --
The U.S. equity market kicked off the third quarter of 2013 on a positive note as all three benchmark indexes edged higher on Monday, July 1, 2013. Stocks gained as better-than-expected ISM manufacturing and construction spending data lifted market sentiment. However, all three benchmark indexes finished well off their session highs. The healthcare sector was among the major gainers in the S&P 500 on Monday, and the major movers in this sector included ISIS Pharmaceuticals Inc. (NASDAQ: ISIS), Community Health Systems (NYSE: CYH), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), and Alere Inc. (NYSE: ALR). AAAResearchReports.com tracked ISIS, CYH, ZIOP, and ALR. These reports can be seen for free at:
http://www.aaaresearchreports.com/register/
Shares in ISIS Pharmaceuticals Inc. surged on Monday, hitting a 52-week high of $29.08. The stock finished 5.95% higher at $28.47. A total of 1.69 million shares were traded which is slightly above the daily average volume of 1.65 million. ISIS Pharma's shares are currently trading above their 50-day and 200-day moving averages. In the last three months, the company's shares have gained 67.27%, thus outperforming the S&P 500. Download free research on ISIS by signing up now at:
http://www.AAAResearchReports.com/ISIS070213.pdf
Community Health Systems' stock edged higher on Monday, extending its gains from previous trading sessions. The company's shares closed the day 0.32% higher at $47.03 after oscillating between $46.84 and $47.56. A total of 664,938 shares were traded which is below the daily average volume of 1.19 million. The company's shares have gained 1.49% in the last three trading sessions, but have declined 2.08% in the last three months. Moreover, the stock is currently trading near its 52-week high of $51.29. Register for today's free analysis on CYH at:
http://www.AAAResearchReports.com/CYH070213.pdf
Shares in ZIOPHARM Oncology Inc. fluctuated between $2.07 and $2.23 before closing the day flat at $2.11. A total of 615,496 shares were traded which is below the daily average volume of 1.86 million. ZIOPHARM's shares have gained 6.57% in the last three trading sessions and 19.89% in the last three months. A free report on ZIOP can be accessed by registering at:
http://www.AAAResearchReports.com/ZIOP070213.pdf
Alere Inc.'s stock rose sharply on Monday, tracking gains in the broader market. The company's shares ended the day 2.24% higher at $25.05 after oscillating between $24.53 and $25.22. A total of 526,399 shares were traded which is above the daily average volume of 473,067. Alere's shares have fallen 2.19% in the last three months. The stock is still trading above its 200-day moving average. Register with AAA Research Reports and download research on ALR for free at:
http://www.AAAResearchReports.com/ALR070213.pdf
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
SOURCE AAA Research Reports